laitimes

A summary of the latest policies for China's biomedical industry in 2022

author:China Business Intelligence Network

China Business Intelligence Network News: Biomedical engineering is a comprehensive application of life science and engineering science principles and methods, from the perspective of engineering in the molecules, cells, tissues, organs and even the entire human body system multi-level understanding of the structure, function and other life phenomena of the human body, research for disease prevention, treatment, human function assistance and health care of artificial materials, products, devices and system technology general term.

In recent years, China's biomedical industry has been highly valued by governments at all levels and the key support of national industrial policies. The state has successively issued a number of policies to encourage the development and innovation of the biomedical industry, and industrial policies such as the "14th Five-Year Plan" Biomedical Industry Development Plan, the Technical Guidelines for Clinical Comparability of Preventive Vaccines, and the Drug Administration Law of the People's Republic of China provide clear and broad market prospects for the development of the biomedical industry and provide a good production and operation environment for enterprises. The details are listed below:

A summary of the latest policies for China's biomedical industry in 2022

Source: Compiled by China Commercial Industry Research Institute

For more information, please refer to the "Research Report on Market Prospects and Investment Opportunities in China's Biomedical Industry" released by The China Commercial Industry Research Institute, which also provides industrial big data, industrial intelligence, industrial research reports, industrial planning, park planning, 14th Five-Year Plan, industrial investment attraction and other services.